サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1533983

血管塞栓装置の世界市場

Vascular Embolization Devices

出版日
ページ情報
英文 250 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
血管塞栓装置の世界市場
出版日: 2024年08月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 250 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管塞栓装置の世界市場は2030年までに26億米ドルに到達

2023年に19億米ドルと推定される血管塞栓装置の世界市場は、2023年から2030年にかけてCAGR 4.7%で成長し、2030年には26億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるコイリングデバイスは、CAGR 4.2%を記録し、分析期間終了までに16億米ドルに達すると予測されます。非コイリングデバイスセグメントの成長率は、分析期間でCAGR 5.5％と推定されます。

米国市場は5億750万米ドルと推定、中国はCAGR7.6%で成長予測

米国の血管塞栓装置市場は、2023年に5億750万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5億2,330万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.6%です。その他の注目すべき地域市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と4.8%と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界の血管塞栓装置市場- 主な促進要因と動向のまとめ

血管塞栓装置は、血管内の血流を意図的に阻害するために使用される医療器具です。この処置は、出血、動脈瘤、動静脈奇形、特定のがんを含む様々な疾患の治療に不可欠です。これらの器具はコイル、粒子、プラグ、または液体塞栓剤で構成され、カテーテルを介して標的部位に送達されます。血流を遮断することで、出血を抑えたり、血管奇形を小さくしたり、腫瘍への血液供給を遮断したりして、腫瘍の増殖や転移を防ぐことができます。血管塞栓術は低侵襲的な治療法であり、従来の外科的方法に代わる安全な治療法です。

血管塞栓術の分野は，機器技術や材料の絶え間ない改良により，長年にわたって大きな進歩を遂げてきました。最新の血管塞栓術用器具は，より高い精度と有効性を目指して設計されており，その目的を果たすと溶解する生体吸収性材料をしばしば組み込んで，長期的な合併症のリスクを軽減しています。着脱可能なコイルや高度な液体塞栓剤の開発は、複雑な血管病態の治療に革命をもたらしました。リアルタイム透視やMRIガイド下塞栓術のような画像診断の進歩は，これらの手技の精度を高め，よりよい治療成績と回復時間の短縮を可能にしました。さらに、これらの機器の応用は、緊急時の介入だけでなく、子宮筋腫や静脈瘤のような慢性疾患を管理するための選択的処置にまで拡大しています。

血管塞栓装置市場の成長は、いくつかの要因によって牽引されています。第一に、動脈瘤や動静脈奇形などの血管疾患の有病率の増加により、効果的な治療オプションに対する需要が高まっています。第二に、このような状態に陥りやすい世界人口の高齢化が、市場の成長をさらに促進しています。カテーテルベースの送達システムと塞栓材料の技術的進歩は、治療可能な疾患の範囲を広げ、患者の転帰を改善しました。また、特に新興市場におけるヘルスケア・インフラの増加と先進医療技術へのアクセスも、市場拡大に重要な役割を果たしています。さらに、医療機器メーカーと研究機関との戦略的提携が、技術革新と新製品の開発を加速させています。最後に、低侵襲手技の利点に関するヘルスケア専門家や患者の意識の高まりが塞栓装置の採用を後押しし、現代医療におけるその役割を確固たるものにしています。

調査対象企業の例（全86件）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Embolx, Inc.
  • Kaneka Corporation
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic
  • Merit Medical Systems, Inc.
  • NeuroSafe Medical Co., Ltd
  • Penumbra, Inc
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Medical Corporation
  • Wallaby Medical, LLC.
  • Zylox-Tonbridge Medical Technology Co. Ltd.;

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP26612

Global Vascular Embolization Devices Market to Reach US$2.6 Billion by 2030

The global market for Vascular Embolization Devices estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Coiling Devices, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Non-Coiling Devices segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.5 Million While China is Forecast to Grow at 7.6% CAGR

The Vascular Embolization Devices market in the U.S. is estimated at US$507.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$523.3 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Vascular Embolization Devices Market - Key Drivers and Trends Summarized

Vascular embolization devices are medical instruments used to obstruct blood flow within a vessel deliberately. This procedure is critical in treating various conditions, including hemorrhages, aneurysms, arteriovenous malformations, and certain cancers. These devices can consist of coils, particles, plugs, or liquid embolic agents, which are delivered via catheters to the target area. By blocking the blood flow, these devices help to control bleeding, reduce the size of vascular malformations, or cut off blood supply to tumors, thus preventing their growth and spread. Vascular embolization is a minimally invasive procedure, offering a safer alternative to traditional surgical methods.

The field of vascular embolization has seen significant advancements over the years, with continuous improvements in device technology and materials. Modern embolization devices are designed for higher precision and efficacy, often incorporating bioresorbable materials that dissolve after fulfilling their purpose, reducing the risk of long-term complications. The development of detachable coils and advanced liquid embolic agents has revolutionized the treatment of complex vascular conditions. Imaging advancements, such as real-time fluoroscopy and MRI-guided embolization, have enhanced the accuracy of these procedures, allowing for better outcomes and shorter recovery times. Additionally, the application of these devices has expanded beyond emergency interventions to include elective procedures for managing chronic conditions like uterine fibroids and varicose veins.

The growth in the vascular embolization devices market is driven by several factors. Firstly, the increasing prevalence of vascular diseases, such as aneurysms and arteriovenous malformations, has led to a higher demand for effective treatment options. Secondly, the aging global population, which is more prone to such conditions, further fuels market growth. Technological advancements in catheter-based delivery systems and embolic materials have broadened the range of treatable conditions and improved patient outcomes. The rise in healthcare infrastructure and access to advanced medical technologies, particularly in emerging markets, has also played a crucial role in market expansion. Additionally, strategic collaborations between medical device manufacturers and research institutions are accelerating innovation and the development of new products. Finally, increased awareness among healthcare professionals and patients about the benefits of minimally invasive procedures has driven the adoption of embolization devices, solidifying their role in modern medical practice.

Select Competitors (Total 86 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Embolx, Inc.
  • Kaneka Corporation
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic
  • Merit Medical Systems, Inc.
  • NeuroSafe Medical Co., Ltd
  • Penumbra, Inc
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Medical Corporation
  • Wallaby Medical, LLC.
  • Zylox-Tonbridge Medical Technology Co. Ltd.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Vascular Embolization Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Vascular Diseases Propels Demand for Embolization Devices
    • Technological Advancements in Embolization Techniques Enhance Treatment Efficacy
    • Growing Preference for Minimally Invasive Procedures Drives Market Growth
    • Expanding Applications of Embolization Devices in Oncology Spurs Market Expansion
    • Development of Bioabsorbable Embolization Materials Generates Market Interest
    • Integration of AI and Robotics in Vascular Procedures Drives Market Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vascular Embolization Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coiling Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Non-Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Non-Coiling Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Non-Coiling Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Peripheral Vascular Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Peripheral Vascular Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Vascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Vascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Vascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Vascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Vascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Vascular Embolization Devices by Type - Coiling Devices and Non-Coiling Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Vascular Embolization Devices by Type - Percentage Breakdown of Value Sales for Coiling Devices and Non-Coiling Devices for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Vascular Embolization Devices by Application - Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Vascular Embolization Devices by Application - Percentage Breakdown of Value Sales for Neurology Application, Oncology Application, Peripheral Vascular Disease Application and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Vascular Embolization Devices by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Vascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION